RxDoctor Payments Data

Gregory Kirkpatrick

Pediatric Hematology-Oncology · Tulsa, OKNPI 1962489856

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for pediatric hematology-oncology clinicians in OK, where the typical reported total is $292.

$82in general payments, 2019–2025

Across 4 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$41
  • Pfizer$41
$493,722in research payments, 2019–2025

Across 7 payments — averaging $70,532 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Seagen Inc.$411K
  • E.r. Squibb & Sons, L.L.C.$79K
  • Amgen$4K

What the payments were for

  • Food & beverage$82100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis2$41
Pfizer2$41

How this compares

$82 in reported general payments places this provider in the 10th percentile of 25 pediatric hematology-oncology providers in Oklahoma.

See all pediatric hematology-oncology providers in Oklahoma

Other pediatric hematology-oncology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →